Sign up to save your podcasts
Or
Share Episode 61: Personalising Anti-VEGF Treatment in Neovascular AMD: Does Phenotype Matter?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 61: Personalising Anti-VEGF Treatment in Neovascular AMD: Does Phenotype Matter?
Dr. Sarah Mrejen (France), Associate Professor Salomon Cohen (France), and Associate Professor Dinah Zur (Israel) explore how neovascular AMD phenotype may influence imaging choices, patient dialogue, and treatment plans. From proactive vs. conservative strategies to new anti-VEGF agents and PCV diagnosis, this expert-led discussion offers key insights into personalising care in retinal disease.
View all episodes
By Whipsmart Media
5
11 ratings
Dr. Sarah Mrejen (France), Associate Professor Salomon Cohen (France), and Associate Professor Dinah Zur (Israel) explore how neovascular AMD phenotype may influence imaging choices, patient dialogue, and treatment plans. From proactive vs. conservative strategies to new anti-VEGF agents and PCV diagnosis, this expert-led discussion offers key insights into personalising care in retinal disease.
More shows like Talking Euretina
View all
Ophthalmology off the Grid by Eyetube
43 Listeners
New Retina Radio by Eyetube
17 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
The Retina Channel Podcast
11 Listeners
JAMA Medical News
88 Listeners
CRST: The Podcast
8 Listeners
Retina Synthesis
8 Listeners
Headlight in the fog: The Uveitis Podcast
21 Listeners
Experts InSight
52 Listeners
RETINA Journal Podcasts
10 Listeners
Cataract Coach with Uday Devgan MD
16 Listeners
Ophthalmology Journal
18 Listeners
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
0 Listeners
Mayo Clinic Ophthalmology Podcast
17 Listeners
RetinaRounds™
0 Listeners